The Danish town of Kalundborg should be a boom town, as the main manufacturing site for the weight loss drug Wegovy. The pharmaceutical company which makes it, Novo Nordisk, is the most valuable in Europe and has invested $8.5 billion dollars in a new plant there. Despite this economic bounty, Kalundborg’s schools are underperforming and entertainment opportunities are limited. Many young keen people say it’s peaceful but dull and can’t wait to get out to study and work in bigger cities like the capital, Copenhagen. Can the mayor persuade people to move and live there long term?
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast